★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareⓁ PharmaceuticalsMarkets Big Pharma Set to Let Biotech Bleed Continue Before Deploying Massive Cash Balances Throughout the past few months, MRP has highlighted significant cash balances among many biopharmaceutical giants. Though hundreds of billions of dollars…McAlinden Research PartnersJune 14, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets Discounted Biotech Sellers, Rich Pharma Buyers May Finally Revive M&A Activity in Healthcare The acquisition of biotechnology firms is one of the most common ways big pharma replenishes their pipeline of new drugs. However,…McAlinden Research PartnersMay 12, 2022
